Recent Press Releases

FDA approves Jardiance to treat type 2 diabetes

The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes. Type 2 diabetes...

Taiho Pharmaceutical Announces Termination of Phase III Clinical Trial of the Angiogenesis Inhibitor TSU-68 (orantinib) in Patients with Hepatocellular Carcinoma

Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director: Masayuki Kobayashi) announced today its decision to terminate a Phase III clinical trial (ORIENTAL trial) of the...

Loxo Oncology Announces Pricing of Initial Public Offering

STAMFORD, Conn., Aug. 1, 2014 -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced the...

Biota Reports Top-Line Data From Its Phase 2 "IGLOO" Trial of Laninamivir Octanoate

ATLANTA, Aug. 1, 2014 -- Biota Pharmaceuticals, Inc. (BOTA) (the "Company") today announced top-line data from a randomized, double-blind, placebo-controlled, parallel-arm Phase 2 clinical...

Sarepta Therapeutics Announces Appointment of John Hodgman As Interim Chairman

CAMBRIDGE, Mass.--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that John Hodgman, a member of Sarepta's board of directors, has...

Receptos (RCPT) Announces Appointment Of Mary Szela And Richard Heyman, Ph.D. To Board Of Directors - 7/29

SAN DIEGO, July 29, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today...

ISPE Hires Healthcare Association Exec As CEO - 7/29

TAMPA, Fla., July, 29 2014 /PRNewswire-USNewswire/ -- ISPE—the International Society for Pharmaceutical Engineering announced today it has hired John Bournas as President and CEO, succeeding...

Abide Therapeutics Appoints Nancy Thornberry To Board Of Directors - 7/29

SAN DIEGO, July 29, 2014 /PRNewswire/ -- Abide Therapeutics announced today the appointment of Nancy Thornberryto its board of directors. Thornberry was previously senior vice president and franchise...

Gordon Sangster To Join Codexis, Inc. (CDXS) As Senior Vice President & Chief Financial Officer - 7/29

REDWOOD CITY, Calif., July 28, 2014 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that...

ELC Group Appoints Head Of Regulatory Affairs For Russia And CIS

Inna Demidova to head new Moscow office for fast-growing global regulatory affairs specialist Cambridge, UK, 28th July 2014. ELC Group, one of the fastest-growing providers of regulatory affairs,...

Inform Genomics Announces Appointment Of Carl De Moor, Phd, As Chief Technology Officer

Boston, MA, July 28, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc, a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...

Arthur J. Tipton, Ph.D., Named President Of Controlled Release Society

BIRMINGHAM, Ala., July 28, 2014 /PRNewswire-USNewswire/ -- Southern Research Institute today announced that Arthur J. Tipton, Ph.D., President and CEO of Southern Research Institute, has been named...

ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development

LOS ANGELES, SINGAPORE, and TOKYO, July 28, 2014 /PRNewswire/ -- ImaginAb, Inc. today announced today announced that it has appointed Roger Crystal, MD as Vice President of Business Development. Dr....

Egalet Appoints Jeffrey M. Dayno, M.D. As Chief Medical Officer

WAYNE, Pa., July 28, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet") today announced the appointment of Jeffrey M. Dayno, M.D. as chief medical officer (CMO). Dr. Dayno...

American Diabetes Association Announces Interim CEO

ALEXANDRIA, VA--(Marketwired - July 28, 2014) - The American Diabetes Association (Association) today announced that Suzanne Berry, MBA, CAE has been named interim chief executive officer until a...

Sarepta Therapeutics Announces Appointment of John Hodgman As Interim Chairman

Sarepta Therapeutics Announces Appointment of John Hodgman As Interim Chairman CAMBRIDGE, Mass., Jul 31, 2014 (BUSINESS WIRE) -- Sarepta Therapeutics, Inc. SRPT -6.93%, a developer of innovative...

Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest

MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...

Marathon Pharmaceuticals Names Jeanine Swalec Vice President of Regulatory Affairs

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals today announced Jeanine M. Swalec has joined the company as its vice president of regulatory affairs. Swalec, 45, most recently served as...

MYOS (MYOS) Announces Appointment Of Douglas Weekes As Chief Commercial Officer

CEDAR KNOLLS, NJ--(Marketwired - July 30, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the...

Aegerion Pharmaceuticals, Inc. (AEGR) Appoints Craig Fraser As Chief Operating Officer

CAMBRIDGE, Mass., July 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...